Matt Dolan

Matthew Dolan is Executive Vice President, Strategy, Corporate Development, and Dexcom Labs at DexCom Inc. a company that develops diabetic monitoring and managing systems. As the Senior Vice President, Dolan established a new division within Dexcom, which now exceeds 100 FTEs and includes three independent target segments. Matt Dolan initially served as DexCom, Inc.'s Vice President of Corporate Development, leading key partnerships with major players like Eli Lily. Beyond immediate success, he presented a long-term strategy to the board, focusing on core projects and emerging markets. His success resulted in a shift in corporate culture, leading to his current role as Senior Vice President and General Manager of New Markets. Matthew Dolan earned his Bachelor of Arts in Economics from Northwestern University. Today, Matthew Dolan leads the New Markets division, which he was instrumental in establishing. This division now encapsulates nearly 100 employees and covers multiple target markets including population health, patient monitoring, and pregnancy. Additionally, he has built and initiated a roadmap for evidence-based strategizing and product development. His work with DexCom has been among the most rewarding and fulfilling work of his life, and he looks forward to many more years of work with the company. Outside of work, Matthew enjoys surfing, skiing, running, and mountain biking with family and friends. Dolan thoroughly enjoys music and can be often times found playing the piano or guitar. Check out Matthew Dolan’s website today for more information!